Cargando…

Microbiome Related Cytotoxically Active CD8+ TIL Are Inversely Associated With Lung Cancer Development

Lung cancer is the most common cancer type around the world. Although major advances in cancer therapy, lung cancer has been the largest proportion of all cancer-related deaths. The respiratory tract contains many types of bacteria and a distinct lung microbiome in lung cancer patients was described...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Leliang, Xu, Jiaqi, Sai, Buqing, Zhu, Yinghong, Wang, Lujuan, Yin, Na, Yu, Fenglei, Zhou, Wen, Wu, Minghua, Tang, Jingqun, Xiang, Juanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756114/ https://www.ncbi.nlm.nih.gov/pubmed/33363002 http://dx.doi.org/10.3389/fonc.2020.531131

Ejemplares similares

Lung microbiome alterations in NSCLC patients
por: Zheng, Leliang, et al.
Publicado: (2021)

Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
por: Zhang, Xina, et al.
Publicado: (2019)

Ligand-independent EphB1 signaling mediates TGF-β-activated CDH2 and promotes lung cancer cell invasion and migration
por: Wang, Lujuan, et al.
Publicado: (2020)

Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs
por: Sai, Buqing, et al.
Publicado: (2019)

Exosomes from cisplatin-induced dormant cancer cells facilitate the formation of premetastatic niche in bone marrow through activating glycolysis of BMSCs
por: Xu, Jiaqi, et al.
Publicado: (2022)

Lipids for CD8(+) TILs: Beneficial or harmful?
por: Wu, Duojiao, et al.
Publicado: (2022)

Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
por: Xu, Jiaqi, et al.
Publicado: (2021)

Association between radiomics features of DCE-MRI and CD8(+) and CD4(+) TILs in advanced gastric cancer
por: Huang, Huizhen, et al.
Publicado: (2023)

Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress
por: Dai, Yafei, et al.
Publicado: (2016)

Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1
por: Yunger, Sharon, et al.
Publicado: (2023)

Chromatin accessibility regulates chemotherapy-induced dormancy and reactivation
por: Wang, Lujuan, et al.
Publicado: (2021)

Exploration of lung mycobiome in the patients with non-small-cell lung cancer
por: Zhao, Yiming, et al.
Publicado: (2023)

CD8+ TILS Expression in Invasive Breast Carcinoma (No Special Type)
por: Astuti, Astuti, et al.
Publicado: (2022)

Cis-regulatory functions of overlapping HIF-1alpha/E-box/AP-1-like sequences of CD164
por: Tang, Jingqun, et al.
Publicado: (2011)

Cell-cell contact-driven EphB1 cis- and trans- signalings regulate cancer stem cells enrichment after chemotherapy
por: Wang, Lujuan, et al.
Publicado: (2022)

Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential
por: Jiménez-Reinoso, Anaïs, et al.
Publicado: (2021)

Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions
por: Teng, Feifei, et al.
Publicado: (2016)

Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer.
por: Palomero, Jara, et al.
Publicado: (2022)

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients
por: Kvistborg, Pia, et al.
Publicado: (2012)

Classification of gallbladder cancer by assessment of CD8(+) TIL and PD-L1 expression
por: Lin, Jianzhen, et al.
Publicado: (2018)

NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8(+) T Cells
por: Bhuniya, Avishek, et al.
Publicado: (2020)

Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC
por: von Witzleben, Adrian, et al.
Publicado: (2021)

Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy
por: Sai, Buqing, et al.
Publicado: (2018)

Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ
por: Farolfi, Alberto, et al.
Publicado: (2020)

PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2022)

Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer
por: Wang, Yumeng, et al.
Publicado: (2022)

Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients
por: Cao, Pengfei, et al.
Publicado: (2017)

Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk “Infiltrating” HPV(−) HNSCC
por: Xu, Ke, et al.
Publicado: (2020)

Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors
por: Baram, Tamir, et al.
Publicado: (2021)

High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease
por: Nota, Sjoerd P. F. T., et al.
Publicado: (2021)

A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells
por: Cameron, Cheryl M., et al.
Publicado: (2023)

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer
por: Wang, Qiang, et al.
Publicado: (2021)

High post‐chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy
por: Jia, Wenxiao, et al.
Publicado: (2023)

CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
por: Rathore, Ankita Singh, et al.
Publicado: (2014)

CD8+ TIL Recruitment May Revert the Association of MAGE A3 with Aggressive Features in Thyroid Tumors
por: Martins, Mariana Bonjiorno, et al.
Publicado: (2014)

Deciphering Microenvironment of NSCLC based on CD8+ TIL Density and PD-1/PD-L1 Expression
por: Lin, Ziying, et al.
Publicado: (2019)

Uncovering PD-L1 and CD8(+) TILS Expression and Clinical Implication in Cervical Squamous Cell Carcinoma
por: Chen, Jingjing, et al.
Publicado: (2020)

Concordance of PD-L1 expression and CD8(+) TIL intensity between NSCLC and synchronous brain metastases
por: Batur, Sebnem, et al.
Publicado: (2020)

CD8(+) TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens
por: Lee, Sung-Woo, et al.
Publicado: (2021)

Fysikkpris til Fanamann
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_9stelsqr5fplmjfejf1k9tnt9s